Fulgent Genetics | About Us

Our mission is to develop flexible and affordable diagnostics and therapeutics that improve the everyday lives of those around us.

Our History

Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform.

Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike.

Since integrating with our therapeutic development business, Fulgent is also developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. By merging our fields of expertise, we aim to become a fully integrated precision medicine company.

Our Values

Innovation

By merging the fields of genetics, molecular biology, and computer science, we pursue excellence in clinical diagnostics, therapeutic development, and data analysis.

Customer Service & Commitment

Our dedicated team of customer support staff is available to answer questions quickly and accurately, so physicians can spend more time with what's really important: their patients.

Quality & Efficiency

As a CLIA-certified and CAP-accredited lab, quality controls are built into our procedures at every step, and multiple lab directors oversee all clinical procedures and analysis.

Our People

We support our employees by providing them with resources for personal and professional growth while fostering an inclusive culture where differences are celebrated.

Our Laboratory

Fulgent Genetics was the first clinical laboratory to offer copy number variation detection using NGS technology in the United States. Today, we continue to offer an unrivaled catalog of genetic testing, including over 18,000+ single gene tests, 900+ rare disease tests, whole genome sequencing, whole genome copy number variation analysis, mitochondrial sequencing, and CLIA/CAP quality sequencing services.

We currently operate 7 labs across the United States, all of which are CLIA-certified and CAP-accredited and meet the highest standards of diagnostic testing. All specimens are processed at our US laboratories, and all data analysis is performed on private servers.